In 2020, 2021, and 2022 we were acknowledged as one of the top 10 pharma analytics companies in Europe by the magazine Pharma Tech Outlook. The magazine brings thought leadership articles from industry veterans and is read by almost 100.000 subscribers across Europe. For Intellishore, this is a culmination of many years of dedicated work and successful projects, bringing our deep industry knowledge and technology expertise to our clients.
Healthcare companies face increasing analytical challenges caused by the growing volume and diversity of available data, complex IT ecosystems, and an ever-increasing demand for insights. With new technologies paving the way for innovative methods for analyzing and processing data, we are excited to continue our mission to deliver successful digital transformations to the healthcare industry.
At Intellishore, we have built a deep understanding, and extensive experience delivering strategic and technical data & analytics solutions within everything from R&D to Commercial Excellence in Healthcare. We have executed a multitude of digital transformation projects for some of the leading public and private organizations. Our network consists of +50 visionary healthcare players across the value chain, and we often host knowledge-sharing sessions where we bring together some of the industry thought leaders with the intention of strengthening the overall digital maturity of the healthcare industry.
While we are incredibly proud of our projects in clinical operations, supply chain management, and other areas, there is no doubt that commercial analytics is a domain for which we have a special predilection. We have profound experience in empowering commercial leaders across brand, launch, marketing, and field force teams. Our history and track record have enabled us to guide healthcare companies on their journey towards accelerating commercial growth and ultimately ensuring that personas across the organization have access to relevant and timely insights.
Achieving commercial excellence is ultimately determined by companies’ strategic ability to anticipate and quickly respond to emerging market opportunities – constantly adjusting where to play and how to win. Our experience reveals that the foundation for commercial excellence requires the correlation of three distinct areas:
001 | Cross-Value Chain Analytics Strategy
Prioritizing analytics efforts across R&D, manufacturing, and commercial operations
002 | Integrating and Democratizing Data
Building a scalable platform for seamless data sharing between e.g. Research and Clinical Ops.
003 | Fueling Commercial Analytics
Delivering insights to support business-critical processes e.g. sales force effectiveness
004 | Adoption from Management to Field Force
Tailoring adoption efforts to personas across the organization – anchoring new ways of working
005 | Boosting Forecast Accuracy
Ensuring product supply stability and reducing the risk of stock-outs by strengthened predictions